![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 27, 2017 10:45:59 AM
I realize. It will all come down to the success of the science, how long it takes to get there and how the funds are raised between now and then. Koos has complete control to do whatever he wants and in that regard, who Koos is does and always will have an impact on the company, price of stock and future transaction in addition to the science.
In my mind, not much has changed from the stickered post of a year ago. The science may very well succeed - to what profit of investors is up for debate. Those with more than 1M shares may do very well.
If Koos had been issuing shares of RGBP at $1.00/share to raise funds as he recently did for Zander, we'd all be doing well I imagine, but he didn't and the stock price currently reflects that. How many shares he issues between now and any deal will directly impact the pricing, that's basically all I'm saying with Koos holding the key.
I will be interested in reading the upcoming 10-Q filing and seeing what has happened with volume of shares OS and at what price.
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM